Assessment of Host-targeted Nanobody Therapeutics

Agency: DEPT OF DEFENSE
State: Maryland
Type of Government: Federal
FSC Category:
  • A - Research and development
NAICS Category:
  • 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set Aside: No Set aside used
Posted Date: Jan 7, 2026
Due Date: Jan 21, 2026
Solicitation No: HT942626QE003
Original Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page

Description

Follow
Assessment of Host-targeted Nanobody Therapeutics
Active
Contract Opportunity
Notice ID
HT942626QE003
Related Notice
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEFENSE HEALTH AGENCY (DHA)
Office
DEFENSE HEALTH AGENCY
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information
  • Contract Opportunity Type: Sources Sought (Original)
  • Original Published Date: Jan 07, 2026 01:26 pm EST
  • Original Response Date: Jan 21, 2026 10:00 am EST
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: Feb 05, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside: No Set aside used
  • Product Service Code: AJ11 - GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
  • NAICS Code:
    • 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
  • Place of Performance:
    Frederick , MD 21701
    USA
Description

Numerous neurotropic viral families are considered high priority pathogens to the Department of War (DOW), but the therapeutic decelopment in stymied by the difficulty of trafficking into into the Central Nervous System (CNS). This is mediated primarily by blood-brain barrier (BBB) tight junctions that prevent large molecules entry into the parenchymal space. However, the CNS has significant physiologically needs in the form of energy, oxygen and other molecular components. See Statement of Objectives (SOO) for specific information.


Attachments/Links
Contact Information
Contracting Office Address
  • MEDICAL R & D CONTRACTING DIVISION 1 808 SCHREIDER STREET
  • FORT DETRICK , MD 21702
  • USA
Primary Point of Contact
Secondary Point of Contact
History
  • Jan 07, 2026 01:26 pm ESTSources Sought (Original)

Related Document

Jan 12, 2026[Sources Sought (Updated)] Assessment of Host-targeted Nanobody Therapeutics
Get Government Bids Like This by Email Receive daily bid alerts that match your keywords, business categories, and target regions.

See Also

Follow Request for Information (RFI) for Navy Collaborative Combat Aircraft Increment 1 Prototype

DEPT OF DEFENSE

Due by 9/18/2026

Follow Distributed Aperture Resilient Terminal System (DARTS) Active Contract Opportunity Notice ID W56KGU-26-R-0230

DEPT OF DEFENSE

Due by 9/30/2026

Follow Sepsis Research Blood Sample Collection Services Active Contract Opportunity Notice ID HT942523P0084

DEPT OF DEFENSE

Due by 10/15/2026

Follow W56KGU-22-R-0ESI BAA Amendment 0009 Active Contract Opportunity Notice ID W56KGU22ROESI Related Notice

DEPT OF DEFENSE

Due by 10/31/2027

* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.